Literature DB >> 1550462

Psychiatric comorbidity in DSM-III-R hypochondriasis.

A J Barsky1, G Wyshak, G L Klerman.   

Abstract

Forty-two DSM-III-R hypochondriacs from a general medical clinic were compared with a random sample of 76 outpatients from the same setting. Patients completed a research battery that included a structured diagnostic interview (Diagnostic Interview Schedule) and self-report questionnaires to measure personality disorder caseness, functional impairment, and hypochondriacal symptoms. Psychiatric morbidity in the hypochondriacal sample significantly exceeded that of the comparison sample. Hypochondriacs had twice as many lifetime Axis I diagnoses, twice as many Diagnostic Interview Schedule symptoms, and three times the level of personality disorder caseness as the comparison group. Of the hypochondriacal sample, 88% had one or more additional Axis I disorders, the overlap being greatest with depressive and anxiety disorders. One fifth of the hypochondriacs had somatization disorder, but the two conditions appeared to be phenomenologically distinct. Hypochondriacal patients with coexisting anxiety and/or depressive disorder (secondary hypochondriasis) did not differ greatly from hypochondriacal patients without these comorbid conditions (primary hypochondriasis). Because the nature of hypochondriasis remains unclear and requires further study, we suggest that its nosologic status not be altered in DSM-IV.

Entities:  

Mesh:

Year:  1992        PMID: 1550462     DOI: 10.1001/archpsyc.1992.01820020021003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  17 in total

1.  Somatization Disorder.

Authors:  Donald M. Hilty; James A. Bourgeois; Celia H. Chang; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 2.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

3.  Health anxiety symptoms in children and adolescents diagnosed with OCD.

Authors:  Anna Villadsen; Mette V Thorgaard; Katja A Hybel; Jens Søndergaard Jensen; Per H Thomsen; Charlotte U Rask
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-06-29       Impact factor: 4.785

4.  The development and validation of a Chinese version of the Illness Attitude Scales: an investigation of university students.

Authors:  Danyan Luo; Yinxi Zhang; Enyan Yu; Yunfei Tan; Zhou Tong; You Zhou; Wanzhen Chen; Hao Chai; Wei Wang
Journal:  Int J Behav Med       Date:  2014-08

5.  Somatoform symptoms in depressive and panic syndromes.

Authors:  W Rief; W Hiller; M M Fichter
Journal:  Int J Behav Med       Date:  1995

Review 6.  Toward a Lifestyle Medicine Approach to Illness Anxiety Disorder (Formerly Hypochondriasis).

Authors:  Amy S Chappell
Journal:  Am J Lifestyle Med       Date:  2018-04-27

7.  The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health.

Authors:  Per Fink; Eva Ørnbøl; Kaj Sparle Christensen
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 8.  Psychogenic movement disorders: diagnosis and management.

Authors:  Madhavi Thomas; Joseph Jankovic
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  "Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

Authors:  Koen Demyttenaere; Anne Verhaeghen; Nicolas Dantchev; Luigi Grassi; Angel L Montejo; David G S Perahia; Deborah Quail; Catherine Reed; Andre Tylee; Michael Bauer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

10.  Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression.

Authors:  Luigi Grassi; Andrea Rossi; Alessandra Barraco
Journal:  Ann Gen Psychiatry       Date:  2009-05-29       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.